Bizily Scott bought FDMT
March 18, 2024 · Form 4 insider transaction
Bizily Scott bought 500 shares of 4D Molecular Therapeutics, Inc. at $6.49 per share, a transaction worth $3.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
500
Price
$6.49
Total value
$3.2K
InsiderBizily Scott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 18, 2024
Filing dateMarch 20, 2024
Shares owned after2,237
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on October 10, 2023.